IK-930

DB18149InvestigationalSmall molecule

IK-930 is an oral, paralog-selective TEAD inhibitor.

Mechanism: Pharmacologically active on Transcriptional enhancer factor TEF-1, Transcriptional enhancer factor TEF-3, and Transcriptional enhancer factor TEF-4
Curator reviewed
Code names: IK-930

Resolves to

Compound

Targets

What you can answer from here — as of July 19, 2026

4Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

1Clinical trialPhase, status and sponsor resolved per trial

20+ReferencesStructured and connected to the statements they support

Which drugs share a target with IK-930, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.